Long-term stability of PBCA nanoparticle suspensions.
In this study, the stability of poly(butyl cyanoacrylate) (PBCA) nanoparticle suspensions was examined for up to 1 year by measuring the nanoparticle sizes. The nanoparticles were prepared with different stabilizers (dextran 70.000, poloxamer 188, or polysorbate 85), and the particle size was determined before and after purification by centrifugation and after dilution with different solutions (0.1 N HCl, 0.01 N HCl, H2O, and PBS). The most constant sizes were with the untreated acidic nanoparticle suspensions. In all other cases, agglomeration of the particles occurred: the extent of this agglomeration and the time at which the agglomeration occurred depended on the experimental conditions. Nanoparticle polymer degradation, as indicated by size decrease, was not observed. Thus, PBCA nanoparticles can be stored as suspensions, making the lyophilization and the sometimes problematic resuspension by ultrasonication, unnecessary, which is advantageous for clinical applications.
Sommerfeld
P
P
Institute of Medical Psychology, Otto-von-Guericke University, Medical Faculty, Magdeburg, Germany.
Sabel
B A
BA
Schroeder
U
U
D002214:Capsules / Q000138:chemical synthesis / Q000737:chemistry* / Q000302:isolation & purification; D002498:Centrifugation; D003911:Dextrans; D004339:Drug Compounding / Q000379:methods*; D004355:Drug Stability; D004356:Drug Storage; D004659:Enbucrilate / Q000737:chemistry*; D005079:Excipients; D006851:Hydrochloric Acid / Q000378:metabolism; D006863:Hydrogen-Ion Concentration; D008823:Micelles; D020442:Poloxamer; D011108:Polymers / Q000737:chemistry; D011136:Polysorbates; D012996:Solutions; D013535:Suspensions; D013696:Temperature; D013997:Time Factors
D002214:Capsules; D003911:Dextrans; D005079:Excipients; D008823:Micelles; D011108:Polymers; D011136:Polysorbates; D012996:Solutions; D013535:Suspensions; D020442:Poloxamer; D004659:Enbucrilate; D006851:Hydrochloric Acid